Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients

Yogish C Kudva, Jenna R. Erickson, Ajay Parsaik, Nassir Rostambeigi, Prabin Thapa, Roshini S. Abraham

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pancreas transplantation is a therapeutic option for the management of complicated Type 1 diabetes mellitus. While standard protocols include use of induction therapy followed by maintenance immunosuppression, the amount, frequency and duration of induction treatment has not been clearly defined. While the effect of various induction regimens on lymphocytes has been demonstrated, a prospective immune monitoring approach is not widely used to determine " immunological titration" of immunosuppression. In this study, we analyzed a patient cohort with pancreas after kidney transplantation and measured a wide range of quantitative and functional T and B cell parameters to identify those that would provide greatest value in personalized prospective immune assessment and design of immunosuppression. While there were significant quantitative differences observed in the 2 groups of PAK patients for various lymphocyte subsets, the notable observation was that lymphocyte subset quantitation was uninformative with regard to T cell function. Patients with normal lymphocyte counts had impaired T cell functional responses and vice versa. The use of immune monitoring to determine optimal IS regimens needs to be studied further to facilitate personalized management of immunosuppression with reduced risk of allograft rejection in PAK, and limited morbidity and mortality related to infection and malignancy.

Original languageEnglish (US)
Pages (from-to)738-745
Number of pages8
JournalHuman Immunology
Volume74
Issue number6
DOIs
StatePublished - Jun 2013

Fingerprint

Immunologic Monitoring
Immunosuppression
Pancreas
Kidney
Lymphocyte Subsets
T-Lymphocytes
Pancreas Transplantation
Lymphocyte Count
Type 1 Diabetes Mellitus
Kidney Transplantation
Allografts
B-Lymphocytes
Therapeutics
Maintenance
Observation
Lymphocytes
Morbidity
Mortality
Transplant Recipients
Infection

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients. / Kudva, Yogish C; Erickson, Jenna R.; Parsaik, Ajay; Rostambeigi, Nassir; Thapa, Prabin; Abraham, Roshini S.

In: Human Immunology, Vol. 74, No. 6, 06.2013, p. 738-745.

Research output: Contribution to journalArticle

Kudva, Yogish C ; Erickson, Jenna R. ; Parsaik, Ajay ; Rostambeigi, Nassir ; Thapa, Prabin ; Abraham, Roshini S. / Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients. In: Human Immunology. 2013 ; Vol. 74, No. 6. pp. 738-745.
@article{a6756946447e4c2289799ea5863b03ef,
title = "Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients",
abstract = "Pancreas transplantation is a therapeutic option for the management of complicated Type 1 diabetes mellitus. While standard protocols include use of induction therapy followed by maintenance immunosuppression, the amount, frequency and duration of induction treatment has not been clearly defined. While the effect of various induction regimens on lymphocytes has been demonstrated, a prospective immune monitoring approach is not widely used to determine {"} immunological titration{"} of immunosuppression. In this study, we analyzed a patient cohort with pancreas after kidney transplantation and measured a wide range of quantitative and functional T and B cell parameters to identify those that would provide greatest value in personalized prospective immune assessment and design of immunosuppression. While there were significant quantitative differences observed in the 2 groups of PAK patients for various lymphocyte subsets, the notable observation was that lymphocyte subset quantitation was uninformative with regard to T cell function. Patients with normal lymphocyte counts had impaired T cell functional responses and vice versa. The use of immune monitoring to determine optimal IS regimens needs to be studied further to facilitate personalized management of immunosuppression with reduced risk of allograft rejection in PAK, and limited morbidity and mortality related to infection and malignancy.",
author = "Kudva, {Yogish C} and Erickson, {Jenna R.} and Ajay Parsaik and Nassir Rostambeigi and Prabin Thapa and Abraham, {Roshini S.}",
year = "2013",
month = "6",
doi = "10.1016/j.humimm.2013.02.004",
language = "English (US)",
volume = "74",
pages = "738--745",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients

AU - Kudva, Yogish C

AU - Erickson, Jenna R.

AU - Parsaik, Ajay

AU - Rostambeigi, Nassir

AU - Thapa, Prabin

AU - Abraham, Roshini S.

PY - 2013/6

Y1 - 2013/6

N2 - Pancreas transplantation is a therapeutic option for the management of complicated Type 1 diabetes mellitus. While standard protocols include use of induction therapy followed by maintenance immunosuppression, the amount, frequency and duration of induction treatment has not been clearly defined. While the effect of various induction regimens on lymphocytes has been demonstrated, a prospective immune monitoring approach is not widely used to determine " immunological titration" of immunosuppression. In this study, we analyzed a patient cohort with pancreas after kidney transplantation and measured a wide range of quantitative and functional T and B cell parameters to identify those that would provide greatest value in personalized prospective immune assessment and design of immunosuppression. While there were significant quantitative differences observed in the 2 groups of PAK patients for various lymphocyte subsets, the notable observation was that lymphocyte subset quantitation was uninformative with regard to T cell function. Patients with normal lymphocyte counts had impaired T cell functional responses and vice versa. The use of immune monitoring to determine optimal IS regimens needs to be studied further to facilitate personalized management of immunosuppression with reduced risk of allograft rejection in PAK, and limited morbidity and mortality related to infection and malignancy.

AB - Pancreas transplantation is a therapeutic option for the management of complicated Type 1 diabetes mellitus. While standard protocols include use of induction therapy followed by maintenance immunosuppression, the amount, frequency and duration of induction treatment has not been clearly defined. While the effect of various induction regimens on lymphocytes has been demonstrated, a prospective immune monitoring approach is not widely used to determine " immunological titration" of immunosuppression. In this study, we analyzed a patient cohort with pancreas after kidney transplantation and measured a wide range of quantitative and functional T and B cell parameters to identify those that would provide greatest value in personalized prospective immune assessment and design of immunosuppression. While there were significant quantitative differences observed in the 2 groups of PAK patients for various lymphocyte subsets, the notable observation was that lymphocyte subset quantitation was uninformative with regard to T cell function. Patients with normal lymphocyte counts had impaired T cell functional responses and vice versa. The use of immune monitoring to determine optimal IS regimens needs to be studied further to facilitate personalized management of immunosuppression with reduced risk of allograft rejection in PAK, and limited morbidity and mortality related to infection and malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84877061939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877061939&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2013.02.004

DO - 10.1016/j.humimm.2013.02.004

M3 - Article

C2 - 23474226

AN - SCOPUS:84877061939

VL - 74

SP - 738

EP - 745

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 6

ER -